Earnings History Data for Exagen Inc. (XGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Exagen Inc.

Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		XGN	Exagen Inc.	49.55	-0.28	-0.30	-0.31	Exagen GAAP EPS of -$0.28, revenue of $12.5M [11/12/2024 9:39 AM]	2.75	-0.23 (-7.58%)	3.00	0.03 (1.01%)	1.30 - 3.71	42,548	20,000	1,055
Exagen GAAP EPS of -$0.28, revenue of $12.5M [11/12/2024 9:39 AM] Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect [Nov-11-24 07:25AM]
05-08-2024	PM		XGN	Exagen Inc.	34.92	-0.16	-0.36	-0.28	Exagen GAAP EPS of $0.16 beats by $0.50, revenue of $15.1M beats by $1.97M [8/5/2024 9:34 AM]	2.35	0.31 (15.44%)	2.12	0.08 (3.92%)	1.30 - 2.95	398,818	30,000	4,642
Exagen GAAP EPS of $0.16 beats by $0.50, revenue of $15.1M beats by $1.97M [8/5/2024 9:34 AM]
13-05-2024	PM		XGN	Exagen Inc.	24.30	-0.19	-0.40	-0.44	Exagen beats top-line and bottom-line estimates; raises FY24 outlook [5/13/2024 8:03 AM]	1.60	0.03 (1.91%)	1.69	0.12 (7.64%)	1.30 - 3.92	166,697	20,000	16,143
Exagen beats top-line and bottom-line estimates; raises FY24 outlook [5/13/2024 8:03 AM]
18-03-2024	PM		XGN	Exagen Inc.	29.32	-0.31	-0.41	-0.58	Exagen reports Q4 results [3/18/2024 11:27 AM]	1.83	0.21 (12.96%)	1.98	0.36 (22.22%)	1.33 - 3.92	179,522	30,000	12,180
Exagen reports Q4 results [3/18/2024 11:27 AM]
13-11-2023	AH		XGN	Exagen Inc.	25.29	-0.31	-0.50	-0.47	Exagen GAAP EPS of -$0.31 beats by $0.15, revenue of $13.4M beats by $3.07M [11/13/2023 4:28 PM]	1.71	0.25 (17.12%)	1.59	0.13 (8.90%)	1.33 - 4.20	68,529	10,000	513
Exagen GAAP EPS of -$0.31 beats by $0.15, revenue of $13.4M beats by $3.07M [11/13/2023 4:28 PM]
07-08-2023	PM		XGN	Exagen Inc.	41.39	-0.28	-0.47	-0.78	Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook [8/7/2023 8:09 AM]	2.80	0.29 (11.55%)	2.84	0.33 (13.15%)	2.04 - 6.50	93,571	10,000	1,333
Exagen beats Q2 top and bottom line estimates; initiates Q3 outlook [8/7/2023 8:09 AM]
15-05-2023	AH	4:05 PM ET (May 15)	XGN	Exagen Inc.	48.79	-0.44	-0.52	-0.60	Exagen GAAP EPS of -$0.44 beats by $0.12, revenue of $11.2M beats by $1.8M [5/15/2023 4:09 PM]	3.63	0.72 (24.66%)	0.0	0.0 (0.00%)	2.04 - 8.96	204,866	10,000	0
Exagen GAAP EPS of -$0.44 beats by $0.12, revenue of $11.2M beats by $1.8M [5/15/2023 4:09 PM]
20-03-2023	AH	4:05 PM ET (Mar 20)	XGN	Exagen Inc.	45.04	-0.58	-0.71	-0.42	Exagen GAAP EPS of -$0.83 misses by $0.07, revenue of $12.84M beats by $4.14M [3/20/2023 4:10 PM]	2.25	-0.10 (-4.26%)	2.00	-0.35 (-14.89%)	2.04 - 9.44	62,500	20,000	12,219
Exagen GAAP EPS of -$0.83 misses by $0.07, revenue of $12.84M beats by $4.14M [3/20/2023 4:10 PM]
14-11-2022	AH	4:05 PM ET (Nov 14)	XGN	Exagen Inc.	35.61	-0.47	-0.76	-0.42	Exagen GAAP EPS, revenue beats, FY22 guidance raised [11/14/2022 4:08 PM]	2.82	0.72 (34.29%)	0.0	0.0 (0.00%)	2.10 - 14.01	202,535	70,000	0
Exagen GAAP EPS, revenue beats, FY22 guidance raised [11/14/2022 4:08 PM] Exagen stock climbs 47% on raised guidance, stronger-than-expected results [11/15/2022 12:55 PM]
04-08-2022	AH	4:05 PM ET (Aug 4)	XGN	Exagen Inc.	130.37	-0.78	-0.55	-0.38	Exagen GAAP EPS of -$0.78 misses by $0.21, revenue of $8.96M misses by $3.07M [8/4/2022 5:03 PM]	6.34	-1.96 (-23.61%)	3.92	-0.40 (-9.26%)	4.15 - 14.90	73,886	20,000	51,552
Exagen GAAP EPS of -$0.78 misses by $0.21, revenue of $8.96M misses by $3.07M [8/4/2022 5:03 PM] Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA [Aug-04-22 04:06PM] Exagen Inc. Reports Second Quarter 2022 Results [Aug-04-22 04:05PM]
11-05-2022	AH	4:05 PM ET (May 11)	XGN	Exagen Inc.	96.72	-0.60	-0.59	-0.48	Exagen GAAP EPS of -$0.60 beats by $0.01, revenue of $10.4M beats by $0.4M [5/11/2022 4:10 PM]	5.24	-0.26 (-4.73%)	6.56	0.0 (0.00%)	5.01 - 17.58	60,841	70,000	870
Exagen GAAP EPS of -$0.60 beats by $0.01, revenue of $10.4M beats by $0.4M [5/11/2022 4:10 PM] AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates [May-10-22 10:45AM] Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test [May-11-22 04:06PM] Exagen Inc. Reports First Quarter 2022 Results [May-11-22 04:05PM] Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates [May-11-22 05:55PM]
22-03-2022	AH	4:05 PM ET (Mar 22)	XGN	Exagen Inc.	143.22	-0.42	-0.49	-0.27	Exagen GAAP EPS of -$0.42 beats by $0.04, revenue of $12.69M beats by $0.97M [3/22/2022 4:22 PM]	8.90	0.52 (6.21%)	8.79	0.41 (4.89%)	6.84 - 18.86	87,032	30,491	309
Exagen receives DoJ subpoena related to alleged federal healthcare regulations violations [3/23/2022 9:09 AM] Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives [Mar-22-22 04:06PM] Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results [Mar-22-22 04:05PM] Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates [Mar-22-22 05:25PM] Exagen Inc. (XGN) Q4 2021 Earnings Call Transcript [Mar-22-22 10:00PM]
10-11-2021	AH	4:05 PM ET (Nov 10)	XGN	Exagen Inc.	203.84	-0.42	-0.43	-0.34	Exagen EPS beats by $0.02, beats on revenue [11/10/2021 4:22 PM]	14.36	1.16 (8.79%)	13.20	0.0 (0.00%)	10.12 - 24.67	34,914	40,000	709
Exagen EPS beats by $0.02, beats on revenue [11/10/2021 4:22 PM] Exagen Inc. Reports Third Quarter 2021 Results [Nov-10-21 04:05PM] Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates [Nov-10-21 05:55PM] Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript [Nov-11-21 08:30AM]
09-08-2021	AH	4:05 PM ET (Aug 9)	XGN	Exagen Inc.	201.79	-0.38	-0.50	-0.27	Exagen EPS beats by $0.05, beats on revenue [8/9/2021 4:57 PM]	12.55	2.30 (22.44%)	0.0	0.0 (0.00%)	10.12 - 24.67	643,350	40,000	0
Exagen EPS beats by $0.05, beats on revenue [8/9/2021 4:57 PM] Exagen surges as Q2 financials exceed expectations indicating sequential growth [8/10/2021 11:01 AM] Exagen Inc. Reports Second Quarter 2021 Results [Aug-09-21 04:05PM] Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-21 06:35PM] Exagen Inc. (XGN) Q2 2021 Earnings Call Transcript [Aug-10-21 07:01AM]
11-05-2021	AH	4:05 PM ET (May 11)	XGN	Exagen Inc.	259.47	-0.48	-0.46	-0.44	Exagen EPS misses by $0.03, beats on revenue [5/11/2021 4:29 PM]	12.77	-2.29 (-15.21%)	0.0	0.0 (0.00%)	10.29 - 24.67	116,502	50,000	0
Exagen EPS misses by $0.03, beats on revenue [5/11/2021 4:29 PM] Exagen Inc to Host Earnings Call [May-11-21 02:30PM] Exagen Inc. Reports First Quarter 2021 Results [May-11-21 04:05PM] Exagen Inc. (XGN) Q1 2021 Earnings Call Transcript [May-12-21 02:30AM]
16-03-2021	AH	4:05 PM ET (Mar 16)	XGN	Exagen Inc.	253.30	-0.27	-0.33	-0.27	Exagen EPS beats by $0.11, beats on revenue [3/16/2021 4:29 PM]	21.91	1.61 (7.93%)	21.00	0.51 (2.49%)	10.29 - 24.67	13,543	50,173	1,000
Exagen EPS beats by $0.11, beats on revenue [3/16/2021 4:29 PM] Exagen Inc to Host Earnings Call [Mar-16-21 02:30PM] Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results [Mar-16-21 04:05PM] Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates [Mar-16-21 05:25PM] Exagen Inc. (XGN) Q4 2020 Earnings Call Transcript [Mar-16-21 11:30PM]
10-11-2020	AH	4:05 PM ET (Nov 10)	XGN	Exagen Inc.	199.21	-0.34	-0.48	-11.29	Exagen EPS beats by $0.14, beats on revenue [11/10/2020 4:37 PM]	15.70	-0.35 (-2.18%)	16.04	-0.01 (-0.04%)	10.29 - 29.86	4,313	10,221	3,133